Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
China · Delayed Price · Currency is CNY 21.49
-0.24 (-1.10%)
Sep 18, 2026, 3:04 PM CST
SHE:002262 Revenue
Jiangsu Nhwa Pharmaceutical Co., LTD had revenue of 1.61B CNY in the quarter ending June 30, 2026, with 7.25% growth. This brings the company's revenue in the last twelve months to 6.12B, up 2.94% year-over-year. In the year 2025, Jiangsu Nhwa Pharmaceutical Co., LTD had annual revenue of 5.91B with 3.75% growth.
Revenue (ttm)
6.12B
Revenue Growth
+2.94%
P/S Ratio
3.57
Revenue / Employee
1.02M
Employees
6,003
Market Cap
21.83B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.91B | 213.56M | 3.75% |
| Dec 31, 2024 | 5.70B | 656.13M | 13.01% |
| Dec 31, 2023 | 5.04B | 742.99M | 17.28% |
| Jan 1, 2023 | 4.30B | 362.85M | 9.22% |
| Jan 1, 2022 | 3.94B | 574.36M | 17.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
Revenue RankingsJiangsu Nhwa Pharmaceutical Co., LTD News
- 4 weeks ago - Jiangsu Nhwa Pharmaceutical Co., LTD Quarterly report: H1 2026 - Filings
- 5 months ago - Jiangsu Nhwa Pharmaceutical Co., LTD Annual report: H2 2025 - Filings
- 5 months ago - Jiangsu Nhwa Pharmaceutical Co., LTD Quarterly report: Q1 2026 - Filings
- 9 months ago - Luye Pharma Grants Nhwa Rights To Commercialize Three LAI Antipsychotics In Chinese Mainland - Nasdaq
- 11 months ago - Jiangsu Nhwa Pharmaceutical Co., LTD Quarterly report: Q3 2025 - Filings